BUY CENFORCE (VIAGRA, SILDENAFIL CITRATE) (200 MG/TAB. – 10 TABS)
MAIN PRODUCT DESCRIPTION
Cenforce 200 is an oral tablet containing sildenafil citrate, a phosphodiesterase type-5 (PDE-5) inhibitor. The supplied product information states that each tablet contains 200 mg of sildenafil citrate and that the product is intended for the management of erectile dysfunction (ED).
Sildenafil belongs to a well-established pharmacological class known as PDE-5 inhibitors. These medicines work by influencing the nitric oxide–cyclic guanosine monophosphate (NO–cGMP) signalling pathway involved in penile erection. During sexual stimulation, nitric oxide is released in erectile tissue, leading to an increase in cGMP. cGMP promotes relaxation of smooth muscle and dilation of blood vessels, helping increase blood flow into the penis.
Sildenafil inhibits the PDE-5 enzyme responsible for breaking down cGMP. By slowing cGMP degradation, sildenafil can support the physiological erectile response when sexual stimulation is present.
Product Specifications
- Product: Cenforce 200
- Alternative reference: Viagra / sildenafil
- Active ingredient: Sildenafil citrate
- Strength supplied: 200 mg per tablet
- Dosage form: Tablet
- Route: Oral
- Pack size: 10 tablets
- Pharmacological class: PDE-5 inhibitor
- Manufacturer supplied: Centurion Laboratories Pvt. Ltd.
The supplied information describes Cenforce as an oral sildenafil product. However, the source refers to it as an “extended-release” tablet without providing supporting formulation specifications. That description has therefore not been treated as an established technical characteristic.
Erectile Dysfunction
Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual activity. PDE-5 inhibitors such as sildenafil are used to support the physiological mechanisms involved in erection.
Sildenafil does not directly cause an erection in the absence of sexual stimulation. Its activity depends on the normal erectile response being initiated. This is an important distinction when describing the pharmacological action of the medicine.
The supplied information describes an onset of approximately 30–60 minutes and an effective period of several hours. The actual response can vary according to the individual, food intake, other medicines and underlying health conditions.
Mechanism of Action
The principal mechanism involves inhibition of phosphodiesterase type 5 (PDE-5).
The process can be summarised as follows:
Sexual stimulation → nitric oxide release → increased cGMP → smooth-muscle relaxation → increased penile blood flow → erection
PDE-5 normally breaks down cGMP. Sildenafil inhibits PDE-5, allowing cGMP activity to persist for longer and supporting the erectile response.
Because sildenafil acts through this pathway, it is not an anabolic steroid and should not be described as a general stimulant or testosterone-enhancing medicine.
Administration and Food
The supplied source states that sildenafil is taken orally and discusses administration approximately 30–60 minutes before sexual activity. However, treatment should follow the instructions of a qualified healthcare professional and the authorised product information applicable to the particular sildenafil product.
The source also states that large or high-fat meals may delay the onset of sildenafil activity. Alcohol can additionally lower blood pressure and may increase dizziness or other adverse effects in some individuals.
Important Dose Consideration
The supplied product is labelled 200 mg per tablet, which is a high-strength sildenafil presentation. The source also contains a statement that 200 mg is an appropriate dose within 24 hours and recommends starting with 100 mg. These statements have not been reproduced as dosing recommendations.
The appropriate sildenafil dose depends on the individual patient, underlying medical conditions, concurrent medicines and the authorised product information. Patients should not increase the dose or take a higher-strength tablet without medical direction.
Contraindications and Important Safety Considerations
Sildenafil has important contraindications and precautions. In particular, PDE-5 inhibitors can cause significant blood-pressure effects when combined with nitrate medicines used for angina or certain cardiovascular conditions. Such combinations can produce a dangerous fall in blood pressure.
Patients should inform their doctor or pharmacist about all cardiovascular medicines and other treatments they take before using sildenafil.
Medical assessment is particularly important for individuals with cardiovascular disease, low blood pressure, uncontrolled hypertension, previous stroke or myocardial infarction, or other conditions affecting suitability for sexual activity or PDE-5 inhibitor treatment.
Adverse Reactions
The supplied information lists several commonly reported adverse effects associated with sildenafil, including:
- Headache
- Dyspepsia
- Flushing
- Dizziness
- Nasal congestion or runny nose
- Nausea
- Visual disturbances, including blurred vision
Sildenafil can also produce reductions in blood pressure. Rare but serious adverse events require urgent medical attention.
Patients should seek urgent medical care for chest pain, severe allergic symptoms, sudden vision loss, sudden hearing loss or an erection lasting longer than four hours.
Drug Interactions
Sildenafil can interact with medicines that affect blood pressure and cardiovascular function. The most important interaction is with organic nitrates, because combined use can cause marked hypotension.
Other medicines can alter sildenafil exposure or increase the risk of adverse reactions. Patients should provide their healthcare professional with a complete list of prescription medicines, over-the-counter products and supplements before treatment.
Sildenafil should not be combined with another PDE-5 inhibitor or another medicine intended to treat erectile dysfunction unless specifically directed by a qualified healthcare professional.
Sexual Health
Sildenafil supports erectile function but does not provide protection against sexually transmitted infections, including HIV. Appropriate barrier protection and sexual-health precautions remain important where applicable.
Manufacturer and Regulatory Information
The supplied material identifies Centurion Laboratories Pvt. Ltd. as the manufacturer. However, no independent regulatory documentation for the specific Cenforce 200, 200 mg presentation has been supplied.
Accordingly, the product should not be described as “official Viagra,” EU-authorised, prescription-free or legally saleable throughout Europe without verification from the appropriate national or European regulatory authority.
The term “Viagra” should also be used carefully: sildenafil is the active pharmaceutical ingredient associated with Viagra, but Cenforce is a separate branded product.
Important Pharmaceutical Disclaimer
This product contains a prescription-level pharmacologically active substance. Product information should be used together with the applicable official prescribing information and professional medical advice.
The supplied source contains several promotional claims, including claims concerning “stamina,” “performance,” purchasing without prescription and treatment of prostate disorders. These claims have not been incorporated because they are not sufficiently supported by the product information provided.
